Accelerometer-based measures in Friedreich ataxia: a longitudinal study on real-life activity

• Published in: Frontiers in pharmacology Vol. 15; p. 1342965
• Main Authors: Fichera, Mario, Nanetti, Lorenzo, Monelli, Alessia, Castaldo, Anna, Marchini, Gloria, Neri, Marianna, Vukaj, Xhuljano, Marzorati, Mauro, Porcelli, Simone, Mariotti, Caterina
• Format: Journal Article
• Language: English
• Published: Switzerland Frontiers Media S.A 19.03.2024
• Subjects: activity monitor; digital measure; Friedreich ataxia; outcome measures; Pharmacology; wearable sensors; activity monitor; Friedreich ataxia; wearable sensors; outcome measures; digital measure
• ISSN: 1663-9812; 1663-9812
• DOI: 10.3389/fphar.2024.1342965

Quantitative measurement of physical activity may complement neurological evaluation and provide valuable information on patients’ daily life. We evaluated longitudinal changes of physical activity in patients with Friedreich ataxia (FRDA) using remote monitoring with wearable sensors. We performed an observational study in 26 adult patients with FRDA and 13 age-sex matched healthy controls (CTR). Participants were asked to wear two wearable sensors, at non-dominant wrist and at waist, for 7 days during waking hours. Evaluations were performed at baseline and at 1-year follow-up. We analysed the percentage of time spent in sedentary or physical activities, the Vector Magnitude on the 3 axes (VM3), and average number of steps/min. Study participants were also evaluated with ataxia clinical scales and functional tests for upper limbs dexterity and walking capability. Baseline data showed that patients had an overall reduced level of physical activity as compared to CTR. Accelerometer-based measures were highly correlated with clinical scales and disease duration in FRDA. Significantly changes from baseline to l-year follow-up were observed in patients for the following measures: (i) VM3; (ii) percentage of sedentary and light activity, and (iii) percentage of Moderate-Vigorous Physical Activity (MVPA). Reduction in physical activity corresponded to worsening in gait score of the Scale for Assessment and Rating of Ataxia. Real-life activity monitoring is feasible and well tolerated by patients. Accelerometer-based measures can quantify disease progression in FRDA over 1 year, providing objective information about patient’s motor activities and supporting the usefulness of these data as complementary outcome measure in interventional trials.